TRIB

TRIB

USD

Trinity Biotech plc American Depositary Shares

$1.000+0.015 (1.523%)

Reaalajas hind

Healthcare
Meditsiiniseadmed
Iirimaa

Hinnagraafik

Loading Chart...

Põhinäitajad

Turunäitajad
Ettevõtte fundamentaalnäitajad
Kauplemisstatistika

Turunäitajad

Avatud

$0.985

Kõrge

$1.010

Madal

$0.951

Maht

0.15M

Ettevõtte fundamentaalnäitajad

Turukapitalisatsioon

18.6M

Tööstusharu

Meditsiiniseadmed

Riik

Ireland

Kauplemisstatistika

Keskmine maht

4.40M

Börs

NMS

Valuuta

USD

52 nädala vahemik

Madal $0.48Praegune $1.000Kõrge $3.44

Seotud uudised

GlobeNewswire

Trinity Biotech Regains Compliance with Nasdaq Listing Requirements

DUBLIN, Sept. 02, 2025 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq Global Select: TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions, including wearable

Vaata rohkem
Trinity Biotech Regains Compliance with Nasdaq Listing Requirements
GlobeNewswire

Trinity Biotech Appoints Paul Tivnan as Non-Executive Director

DUBLIN, Aug. 21, 2025 (GLOBE NEWSWIRE) -- Trinity Biotech plc (NASDAQ:TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions, including wearable biosensors, today

Vaata rohkem
Trinity Biotech Appoints Paul Tivnan as Non-Executive Director
GlobeNewswire

Regulatory Approval Granted for Commencement of Trinity Biotech's Offshored and Outsourced Manufacturing of its Flagship Rapid HIV Test, Facilitating Strategic and Financial Performance Transformation

Approval Facilitates Immediate Offshored and Outsourced Manufacturing Strategic Offshore Manufacturing Move Expected to Drive Gross Margin Expansion, Free Up Working Capital, and Enhance Scalability Transition to

Vaata rohkem
Regulatory Approval Granted for Commencement of Trinity Biotech's Offshored and Outsourced Manufacturing of its Flagship Rapid HIV Test, Facilitating Strategic and Financial Performance Transformation

Püsi kursis

Määrake hinnateavitused, hankige tehisintellekti analüüsi uuendusi ja reaalajas turuuudiseid.